Marrying Clinical Outcomes with Cost Savings

Interview with Hinge Health President Jim Pursley

In startups, it’s easy to get distracted by shiny technology and forget business fundamentals. For Jim Pursley, who’s sold a company for multiple billions of dollars, success needs to be built on a solid foundation.

That means focusing on proven markets and delivering demonstrable cost savings to both practitioners and patients.

Jim’s approach has worked out well for him. He co-founded Livongo in 2014, took it public in 2019, and sold it to Teladoc in 2020 for $18.5 billion.

Jim’s been the President of Hinge Health since March 2021. Under his leadership, the company is fast establishing itself as the market leader in at-home musculoskeletal physical therapy.

Premium Members Only

Premium Members Only

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You May Like These Articles

Medsider Premium

Become a premium member and unlock access to exclusive Medsider benefits.

Medsider Mentors

Medsider Mentors

Medsider Playbooks

Medsider Playbooks

Playbook

A Guide to Widespread Adoption in Medtech

In medtech, developing novel, impactful technology is often just the starting line. The real race begins when you try to integrate your solution into the often-resistant healthcare system – a hurdle that has tripped up countless promising companies. Here are the key strategies and lessons from five veterans in the medtech space on how to overcome this hurdle.

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest